Legend Biotech, Noile-Immune Biotech in research and licensing agreement
Legend Biotech and Noile-Immune Biotech have entered an agreement which focuses on advancing the next generation of T-cell products for the treatment of solid tumors.
Pharmaceuticals, Biotechnology and Life Sciences
Legend Biotech and Noile-Immune Biotech have entered an agreement which focuses on advancing the next generation of T-cell products for the treatment of solid tumors.
FARGO, N.D.–(BUSINESS WIRE)–#Aldevron–Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Dr. James Brown President…
DENVER–(BUSINESS WIRE)–ClinOne is expanding its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne…
Pfizer invites investors and the general public to listen to a webcast of a discussion with Charles Triano, Senior Vice President, Investor Relations
Cooley lawyers working in the technology and life sciences industries have been advising some of the world’s most innovative companies as they seek to deliver products and services to battle myriad aspects of the COVID-19 pandemic.
HUDSON, Wis.–(BUSINESS WIRE)–Phillips-Medisize, a Molex company, announced the appointment of Paul Chaffin as Senior Vice President and President of the…
Seattle Genetics gets first approval for Tukysa outside of the U.S., Switzerland’s first approval under FDA initiative project orbis.
The revenue decline reflects the following impact of the previously announced Natest SNDS and Estrace shortage in the Canadian market, Acerus said.
Remain on track to resubmit FUROSCIX® NDA with the FDA by mid-year 2020 Strong balance sheet with over $75M in…
Ocular Therapeutix has dosed the first patient in phase 1 clinical trial of OTX-CSI for the treatment of dry eye…